Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect

Michael S Levine1, Carlos Cepeda, Miriam A Hickey

  • 1Mental Retardation Research Center, The David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA. mlevine@mednet.ucla.edu

Trends in Neurosciences
|October 12, 2004
PubMed

Insights

Genetic mouse models offer insights into Huntington's and Parkinson's disease mechanisms. However, these models do not fully replicate the significant cell loss seen in human patients.

Area of Science:

  • Neuroscience
  • Genetics
  • Pharmacology

Background:

  • Genetic mouse models have advanced the study of neurodegenerative diseases like Huntington's and Parkinson's.
  • These models enable early identification of disease manifestations and facilitate mechanistic and drug studies.

Purpose of the Study:

  • To review the utility and limitations of genetic mouse models in understanding Huntington's and Parkinson's diseases.
  • To highlight the differences between model phenotypes and human disease pathology.

Main Methods:

  • Review of existing literature on genetic mouse models for Huntington's and Parkinson's disease.
  • Comparative analysis of disease progression, cellular pathology, and behavioral deficits in models versus human patients.

Main Results:

  • Genetic mouse models exhibit behavioral, neuropathological, and electrophysiological deficits relevant to Huntington's and Parkinson's disease.
  • A key limitation is the failure of current models to replicate the massive, selective cell loss characteristic of human Huntington's and Parkinson's disease.

Conclusions:

  • Genetic mouse models are valuable tools for studying early disease mechanisms and testing therapeutics for Huntington's and Parkinson's disease.
  • Further development of models is needed to accurately recapitulate the full spectrum of human neuropathology, particularly cell loss.

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...